SPECT scan guided radiation to one side of neck for tonsil cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests whether using a detailed scan (SPECT) to guide radiation therapy to only one side of the neck works as well as treating both sides. It is for people with oropharyngeal (tonsil, soft palate, or tongue base) cancer that has not spread to the opposite side of the neck.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of throat cancer (tonsil, soft palate, throat wall, or base of tongue) that is small to medium sized (T1-T3) and has not spread to the opposite side of the neck.
- You are getting radiation therapy to both sides of the neck, with or without chemotherapy, as your main treatment plan.
- You are 18 years or older and feel well enough to carry out daily activities (ECOG 0-1).
- You have had a CT or MRI of your neck, a PET-CT scan, and a chest CT within the last 8 weeks.
- If you are getting chemotherapy, your blood counts, kidney and liver function must be adequate as checked by your doctor.
- You agree to use effective birth control during treatment and for 90 days after radiation, if you could become pregnant or get someone pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give radiation therapy for head and neck cancer. By using a special PET scan to guide where higher radiation doses are given, doctors hope to improve treatment while reducing side effects. It is for people whose cancer is not early-stage and who will receive standard radiation therapy.
This Phase 3 trial tests whether guiding neck radiation by checking the “sentinel” lymph node can target treatment more precisely in certain larynx, hypopharynx, or oropharynx cancers. It aims to improve control while potentially reducing unnecessary radiation to areas that don’t need it.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This trial tests whether patients with early-stage oral cancer who have surgery and lymph-node removal can skip radiation to the neck if certain favorable conditions are met. The goal is to reduce side effects like difficulty swallowing while keeping cancer control strong.
This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.
This trial tests a precise type of radiation called stereotactic radiosurgery for people with head or neck tumors. It may be an option for those who need radiation or chemoradiation as their main treatment or after surgery.
Hear when a new Oropharyngeal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.